Immunology Flashcards
Factors affecting immune health
Chronic stress, physical inactivity, over exercise, poor personal hygiene, impaired microbiota, environmental toxins, lack of sleep, substance abuse, nutrient deficiencies, poor diet
Examples of autoimmune diseases
MS, coeliac’s disease, eczema and psoriasis, asthma, Hashimoto’s thyroid, rheumatoid arthritis
Environmental factors that causes cancer
UV, chemicals, pathogens (HPV causes cervical cancer), smoking
Percentages of cancer caused by transformations of germline cells and somatic cells
Germline (inheritable) <10%
Somatic (noninheritable) >90%
Cancer immunosurveillance
Immune system can recognize and destroy nascent, transformed cells, normal control
Cancer Immunoediting
Tumour tend to be genetically unstable, thus immune system can kill and also induce changes in the tumour resulting in tumour escape and recurrence
Tumour specific antigens
Are only found on tumours, as a result of point mutation or gene rearrangement, Derive from viral antigens
Tumour Associated Antigens (TAA)
-Found on both normal and tumour cells, but are overexpressed on cancer cells
-Developmental antigens which become derepressed. (CEA)
-Differentiation antigens are tissue specific
-Altered modification of a protein could be an antigen
Evidence for human tumour immunity
-Spontaneous regression: melanoma, lymphoma
-Regression of metastases after removal of primary tumour: pulmonary metastases from renal carcinoma
-Infiltration of tumours by lymphocytes and macrophages: melanoma and breast cancer
-Lymphocyte proliferation in draining lymph nodes
-Higher incidence of cancer after immunosuppression, immunodeficiency (AIDS, neonates), aging, etc.
Evidence for Escape (detectable tumours)
-Immune responses change tumours such that tumours will no longer be seen by the immune system: tumour escape
-Tumours change the immune responses by promoting immune suppressor cells: immune evasion
Examples of Active immunotherapy for cancer treatment
Vaccinations ie killed tumour vaccines and purified tumour antigens
Examples of passive immunotherapy for cancer treatment
-Adoptive Cellular Therapy (T cells)
-Anti-tumour Antibodies (Her-2/Neu, CD20, CD10, CEA, CA-125, GD3 ganglioside)
How do cell-based cancer therapy work?
Cellular therapies can be used to activate a patient’s immune system to attack cancer
They can also be used as delivery vehicle to target therapeutic genes to attack the tumour
Do cell-based cancer therapy act directly on cancer cells?
No. They do not act directly on cancer cells. Instead, they work systemically to activate the body’s immune system.
Tumour hypoxia
Hypoxic tumour cells adapt to areas of low oxygen. Prominent feature of malignant tumour. Inability of the blood supply to keep up with growing tumour cells
Problem with tumour hypoxia
Poor patient prognosis
-Stimulates new vessel growth
-Suppresses immune system
-Resistant to radio- and chemotherapy (repopulate the tumour)
-Increased tumour hypoxia after therapy
Passive Immunisation
The administration of pre-formed “immunity” from one person or animal to another person
Passive Immunity Pros and cons
Pros-Gives immediate protection effective in immunocompromised patients
Cons-Short-lived possible transfer of pathogens serum sickness” on transfer of animal sera
-Only humoral (antibody) mediated (not work if cell mediated!)
3 main types of vaccines
-Using whole bacteria/vaccine
-Parts that trigger the immune system
-Genetic material via a vector
Whole microbe vaccine
Bacteria/viruses grown in vitro and inactivated using agents. Don’t cause infection but induce immune response
Limitations of whole microbe vaccine
- The organisms must be grown to high titre in vitro (viruses and some bacteria difficult/expensive to grow in the lab)
- Whole pathogens can cause excessive reactogenicity (i.e., adverse reactions, excessive immunological responses)
- Immune responses are not always close to the normal response to infection, e.g., no mucosal immunity, no CD8 Tc responses
- Usually need at least 2 shots
Live attenuated vaccines
The organisms replicate within the host and induce an immune response which is protective against the wild-type organism but does not cause disease
Attenuation
Where an organism is cultured in such a way that it does not cause disease when inoculated into humans. Lost its pathogenicity but retains its antigenicity
Pros of attenuated vaccines
-Immune response more closely mimics that following real infection because its not fixed – no shape change.
-Better immune response so lower doses are required, so the scale of in vitro growth needed is lower.
-Route of administration may be more favourable (oral).
-Fewer doses may be required to provide protection.
Cons of Live Attenuated Vaccines
- Often impossible to balance attenuation and immunogenicity
- Reversion to virulence
- Transmissibility
- Live vaccines may not be so attenuated in immunocompromised hosts
Why do some pathogens on have vaccines?
-Pathogen too difficult to grow
-Killed pathogen not protective (shape change)
-Impossible to obtain attenuated and suitably immunogenic strain
-Too many strains causing disease etc.
Recombinant proteins vs Synthetic peptides
Recombinant- Genetically Engineered and produced from bacteria, yeast, insect or mammalian cells.
Synthetic- Peptides synthesized directly using a machine - avoids the need for pathogen growth
Live Attenuated Vectors – Viral Vector
These vaccines are composed of living viruses or bacteria that are innocuous to the host but can replicate in host tissues and induce immune responses.
The genes encoding foreign antigens can be inserted into these vectors to produce multivalent vaccines that promise to induce immunity to more than one target disease after the administration of a single dose of vaccine.
DNA vaccines
A mammalian plasmid containing DNA that encodes for the foreign protein (yellow) of interest is injected directly.
This requires a lipid nanocarrier to get the DNA into a human cell. The DNA goes to the nucleus, gets transcribed and the foreign protein expressed with MHC to stimulate the immune response
Innate Immunity
Instinctive, non-specific, does not depend on lymphocytes, present from birth
Adaptive Immunity
Specific ‘Acquired/learned’ immunity, requires lymphocytes, antibodies
Haematopoiesis
The commitment and differentiation processes that leads to the formation of all blood cells from pluripotent haematopoietic stem cells
What determines what BC multipotential hematopoietic stem cell differentiates into
Colony stimulating factors
Examples of Polymorphonuclear
leukocytes
Neutrophil, Eosinophil, basophils
Examples of Mononuclear leukocytes
Monocytes (produces macrophages), T-cells, B-cells (produces plasma cells), Mast cells, natural killer cell, dendritic cells (Kupffer in liver, Langerhans in skin)
Soluble factors in the immune system
Complement
Antibodies
Cytokines, Chemokines
Complement
Group of ~20 serum proteins secreted by the liver that need to be activated to be functional
Modes of action:
1. Direct lysis
2. Attract more Leukocytes to site of infection
3. Coat invading organisms
Antibodies/immunoglobulins
Bind to specific antigens
IgG- must abundant
IgM- 10%, primary immune response
IgA- 15%, main antibody in bodily secretions
IgD- 1%, present on B cells
IgE-0.05%, membrane bound on mast cells, involved in histamine response
Structure of antibodies
2 Heavy chains and 2 light chains, Fab region found on light chains (site for antigen binding), FC region found on heavy chains ( interacts with cell surface receptors)
Epitope
Found on antigen of microbe. Group of amino acids or other chemical groups exposed on the surface of a molecule, frequently a protein, which can generate an antigenic response and bind antibody
Cytokines
proteins secreted by immune and non-immune cells, directs immune response